Top in GI: Drug pipeline for GI conditions; concerns over physician shortage
Click Here to Manage Email Alerts
There were several important FDA approvals for GI conditions over the past year, including the first treatment for eosinophilic esophagitis and the first approved fecal microbiota therapeutic.
Healio compiled a list of the FDA’s decisions on GI therapeutics from 2022 that experts said will change the treatment paradigm in 2023 and beyond. It was the top story in gastroenterology last week.
Another top story covered the shortage of GI physicians amidst an increase in demand for health care providers.
Read these and more top stories in gastroenterology below:
FDA 2022 Rewind: GI drug pipeline rattles as FDA delivers 7 new drugs, 1 costly rejection
Gastroenterology had a big year in 2022, with potentially game-changing FDA approvals for inflammatory bowel disease and several first-in-class therapies, yet the FDA’s rejection of the first hepatitis D therapy still looms large. Read more.
GI physician shortage ‘a significant concern’ affecting both providers, patients
As demand for health care providers continues to increase, the U.S. Department of Health and Human Services reported gastroenterology will be among the top fields with the highest predicted provider deficit. Read more.
Mystery hepatitis culprit still unidentified: Timeline of a global outbreak in children
Since April 2022, more than 1,300 children in 37 countries have developed acute severe hepatitis of unknown etiology, with the United States and the United Kingdom accounting for 65% of global cases, according to recent WHO data. Read more.
Top bariatric surgery news in 2022: Exploring trends in gastric bypass, sleeve gastrectomy
Endoscopic bariatric surgery within the past few years has become a hot topic in the field of gastroenterology as a way to improve outcomes in patients who are obese or have nonalcoholic fatty liver disease. Read more.
Healio wrapped 2022: The best interviews of the year
From CMS challenges to hepatitis outbreaks, FDA approvals to debates over colonoscopy benefit, Healio has been at the forefront of gastroenterology coverage in 2022, alongside a bevy of experts who shared their unique insights with us. Read more.